Frequency Therapeutics Revenue and Competitors

Boston, MA USA

Location

$180.3M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Frequency Therapeutics's estimated annual revenue is currently $24M per year.(i)
  • Frequency Therapeutics received $42.0M in venture funding in January 2019.
  • Frequency Therapeutics's estimated revenue per employee is $828,276
  • Frequency Therapeutics's total funding is $180.3M.
  • Frequency Therapeutics's current valuation is $177.9M. (January 2022)

Employee Data

  • Frequency Therapeutics has 29 Employees.(i)
  • Frequency Therapeutics grew their employee count by -53% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M67-45%$107.3MN/A
#2
$0.2M20%N/AN/A
#3
$4.2M278%N/AN/A
#4
$11.9M77-37%$312.8MN/A
#5
$1.4M50%N/AN/A
#6
$235M246-5%$340.9MN/A
#7
$45.9M237-7%$7.6MN/A
#8
$3.9M5035%N/AN/A
#9
N/A3776%N/AN/A
#10
$5.3M294%N/AN/A
Add Company

Frequency Therapeutics develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue. Through the controlled activation of progenitor cells, Frequency enables disease modification without the complexity of genetic engineering. Our lead program re-creates sensory cells in the inner ear to treat chronic noise induced hearing loss, which affects over 30 million people in the U.S. alone.

keywords:N/A

$180.3M

Total Funding

29

Number of Employees

$24M

Revenue (est)

-53%

Employee Growth %

$177.9M

Valuation

N/A

Accelerator

Frequency Therapeutics's People

NameTitleEmail/Phone
1
SVP ResearchReveal Email/Phone
2
Chief Manufacturing OfficerReveal Email/Phone
3
Chief People OfficerReveal Email/Phone
4
Associate General CounselReveal Email/Phone
5
SVP, Corporate AffairsReveal Email/Phone
6
Senior Director Medicinal ChemistryReveal Email/Phone
7
Senior Scientist IReveal Email/Phone
8
Head Intellectual PropertyReveal Email/Phone
9
ScientistReveal Email/Phone
10
Sr. Research AssociateReveal Email/Phone

Frequency Therapeutics News

2022-04-13 - Frequency Therapeutics Inc (FREQ) Stock Increases 29.29% This Week; Should You Buy?

Frequency Therapeutics Inc (FREQ) stock is lower by -80.79% over the last 12 months, and the average rating from Wall Street analysts is a...

2022-04-06 - MIT scientists have managed to reverse hearing loss with new ...

Frequency Therapeutics, the biotechnology company responsible for the new treatment, was founded in part by scientists from MIT.

2022-03-22 - Reversing hearing loss with regenerative therapy | MIT News ...

The biotechnology company Frequency Therapeutics is seeking to reverse hearing loss — not with hearing aids or implants, but with a new kind...

2019-09-08 - Frequency Plans IPO for Hearing Loss Drug & More ...

Hearing loss affects millions of Americans but to date, there are no FDA-approved medicines to treat them. Frequency Therapeutics is ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.6M29-3%N/A
#2
$2.2M297%N/A
#3
$7M290%N/A
#4
$4.5M29-34%N/A
#5
$10M29-3%N/A

Frequency Therapeutics Funding

DateAmountRoundLead InvestorsReference
2017-04-12$32.0MACoBro VenturesArticle
2019-01-08$42.0MBTaiwania Capital ManagementArticle